Skip to content
Independent analysis of NHS open data
PharmaInsight

Ranolazine 500mg modified-release tablets

0206030Z0AAABAB · Cardiovascular System
Data updated May 2026
34,241items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£199,697

Net ingredient cost · May 2026

NHSBSA PCA

401,311items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Ranolazine 500mg modified-release tablets: national items dispensed by month

0 18k 36k Jul 2023 Jan 2024 Jun 2024 Nov 2024 Apr 2025 Sep 2025 May 2026 34,241 Jul 2023: 24k Aug 2023: 25k Sep 2023: 24k Oct 2023: 25k Dec 2023: 26k Jan 2024: 27k Feb 2024: 25k Mar 2024: 26k Apr 2024: 27k May 2024: 28k Jun 2024: 27k Jul 2024: 29k Aug 2024: 29k Sep 2024: 28k Oct 2024: 30k Nov 2024: 29k Dec 2024: 30k Jan 2025: 31k Feb 2025: 28k Mar 2025: 30k Apr 2025: 31k May 2025: 32k Jun 2025: 31k Jul 2025: 33k Aug 2025: 31k Sep 2025: 33k Oct 2025: 34k Nov 2025: 32k Dec 2025: 36k Jan 2026: 34k Feb 2026: 32k Mar 2026: 35k Apr 2026: 35k May 2026: 34k

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Ranolazine. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).